Annual report [Section 13 and 15(d), not S-K Item 405]

NET LOSS PER SHARE

v3.25.2
NET LOSS PER SHARE
12 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
NET LOSS PER SHARE NET LOSS PER SHARE
Equity Instruments Outstanding
The Company has performance share units and restricted stock units granted under various stock incentive plans that, upon exercise and vesting, would increase shares outstanding.

The following table sets forth the computation of basic and diluted net loss (in thousands, except per share data):
Year Ended March 31,
2025 2024
Numerator:
Net loss used in basic and diluted earnings per share $ (115,091) $ (41,286)
Denominator:
Weighted average common shares outstanding used in basic and diluted earnings per share 5,150  4,754 
Net income loss per share - basic and diluted $ (22.35) $ (8.68)

The dilutive impact related to shares of common stock from incentive plans and outstanding warrants is determined by applying the treasury stock method to the assumed vesting of outstanding performance share units and restricted stock units and the exercise of outstanding options and warrants. The dilutive impact related to shares of common stock from contingently issuable performance share units is determined by applying a two-step approach using both the contingently issuable share guidance and the treasury stock method.

The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive (in thousands):
Year Ended March 31,
2025 2024
Stock awards 127  17 
Warrants 634  608 
Total 761  625 

The Company had outstanding market based restricted stock units as of March 31, 2025 that were eligible to vest into shares of common stock subject to the achievement of certain stock price targets in addition to a time-based vesting period. These contingently issuable shares are excluded from the computation of diluted earnings per share if, based on current period results, the shares would not be issuable if the end of the reporting period were the end of the contingency period. There were 186,616 shares of contingently issuable market-based restricted stock units that were excluded from the table above as the market conditions were not satisfied as of March 31, 2025.